DUBLIN--(BUSINESS WIRE)--The "Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report has been added to Research and Markets' offering.
The global artificial organs market reached a value of more than US$ 12 Billion in 2016.
Rapidly ageing global population and a subsequent increase in the number of people suffering from organ failures represent the key factors driving the artificial organs market. Frequent road accidents and injuries leading to amputations coupled with growing public awareness about advancements in the medical technology have resulted in the demand for artificial organs.
On the other hand, high implantation cost and limited surgical expertise in most regions are expected to restrain the growth of the market. However, the unavailability and scarcity of organ donors at the time of requirement has encouraged the development of artificial organs technology across the globe.
The market is expected to reach a value of more than US$ 20 Billion by 2022, registering a CAGR of around 7%.
Some of the key players are Abiomed, Inc., Heartware International, Inc., Edwards Lifesciences Corp, Boston Scientific Corporation, and Cochlear Limited.
Key Topics Covered:
2 Scope and Methodology
3 Executive Summary
5 Global Artificial Organs Market
6 Market Breakup by Type
7 Market Breakup by Region
8 Competitive Landscape
- Abiomed, Inc
- Boston Scientific Corporation
- Cochlear Limited
- Edwards Lifesciences Corp
- Heartware International, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/dpwzzt/artificial_organs